Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States

Overview of attention for article published in Journal of Infectious Diseases, August 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 11,390 followers.

Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States 🔓 Open Access 🔗 https://t.co/2HbIP6tdI6 https://t.co/UBCnyRgCQF

Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States https://t.co/rlkggIk2Zr

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.